Andrew Diffenbaugh ♛’s Post

View profile for Andrew Diffenbaugh ♛, graphic

Subject Matter Expert Senior Physician Talent Acquisition Lead Spent the entirety of his career in Physician Acquisition. Demonstrated success with large health systems, and publicly traded health Systems for 25 years.

According to a post via Behavioral Health Business, the newest rule the DEA proposes rules that essentially eliminate telehealth-only prescribing for Schedule III to V narcotic and Schedule II non-narcotic controlled substances without a prior in-person examination. There are narrow exceptions for time-limited supplies of non-narcotic drugs and buprenorphine, a popular drug used to treat opioid-use disorder (OUD) before an in-person exam is administered. https://lnkd.in/e7Bhzyvz #oud #telehealth #addictiontreatment #fentanyl #mehadone #mat #otp #asam #behavioralhealth #psychiatry #addiction #andydiffenbaugh

DEA Close to Unveiling New Telehealth Regulations for Controlled Substance Prescriptions

DEA Close to Unveiling New Telehealth Regulations for Controlled Substance Prescriptions

https://bhbusiness.com

To view or add a comment, sign in

Explore topics